• Citer

Prevalence, determinants, and outcomes of nonadherence to imatinib therapy in patients with chronic myeloid leukemia: the ADAGIO study.

par Noens, Lucien;van Lierde, Marie-Anne;De Bock, R;Verhoef, G;Zachée, Pierre;Berneman, Zwi Nisan;Martiat, Philippe ;Mineur, Philippe;Van Eygen, Koen;MacDonald, Karen;De Geest, Sabina;Albrecht, Tara;Abraham, Ivo
Référence Blood, 113, 22, page (5401-5411)
Publication Publié, 2009-05

Article révisé par les pairs

• Détails
• Contenu

Titre:	Prevalence, determinants, and outcomes of nonadherence to imatinib therapy in patients with chronic myeloid leukemia: the ADAGIO study.
Auteur:	Noens, Lucien; van Lierde, Marie-Anne; De Bock, R; Verhoef, G; Zachée, Pierre; Berneman, Zwi Nisan; Martiat, Philippe; Mineur, Philippe; Van Eygen, Koen; MacDonald, Karen; De Geest, Sabina; Albrecht, Tara; Abraham, Ivo
Informations sur la publication:	Blood, 113, 22, page (5401-5411)
Statut de publication:	Publié, 2009-05
Sujet CREF:	Sciences bio-médicales et agricoles
MeSH keywords:	Adolescent
	Adult
	Aged
	Aged, 80 and over
	Antineoplastic Agents -- adverse effects
	Antineoplastic Agents -- therapeutic use
	Case-Control Studies
	Female
	Humans
	Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- drug therapy
	Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- epidemiology
	Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- psychology
	Male
	Middle Aged
	Patient Compliance -- statistics & numerical data
	Piperazines -- adverse effects
	Piperazines -- therapeutic use
	Prevalence
	Pyrimidines -- adverse effects
	Pyrimidines -- therapeutic use
	Retrospective Studies
	Risk Factors
	Treatment Outcome
	Young Adult
Note générale:	Evaluation Studies
	Journal Article
	Multicenter Study
	Research Support, Non-U.S. Gov't
	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:0006-4971
	info:doi/10.1182/blood-2008-12-196543
	info:pii/blood-2008-12-196543
	info:scp/67049087117
	info:pmid/19349618